Blair William & CO Pds Biotechnology Corp Transaction History
Blair William & CO
- $33.4 Billion
- Q3 2024
A detailed history of Blair William & CO transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Blair William & CO holds 121,743 shares of PDSB stock, worth $161,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121,743
Previous 121,743
-0.0%
Holding current value
$161,918
Previous $356,000
30.62%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
63Shares Held
4.05MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.51MShares$2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$647,6660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$552,1000.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$311,4970.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA134KShares$178,5650.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $37.9M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...